156 related articles for article (PubMed ID: 29778099)
21. Impact of invitation and reminder letters on cervical cancer screening participation rates in an organized screening program.
Tavasoli SM; Pefoyo AJ; Hader J; Lee A; Kupets R
Prev Med; 2016 Jul; 88():230-6. PubMed ID: 27143497
[TBL] [Abstract][Full Text] [Related]
22. Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.
Radde K; Gottschalk A; Bussas U; Schülein S; Schriefer D; Seifert U; Neumann A; Kaiser M; Blettner M; Klug SJ
Int J Cancer; 2016 Sep; 139(5):1018-30. PubMed ID: 27083776
[TBL] [Abstract][Full Text] [Related]
23. [How can we improve cervical cancer screening: What can we learn from mistakes?].
Grigore M; Nandrean A; Gafitanu D
Bull Cancer; 2020 Mar; 107(3):322-327. PubMed ID: 32061377
[TBL] [Abstract][Full Text] [Related]
24. Impact of altering the invitation package on screening participation among never-screeners in the Flemish population-based cancer screening programs.
Kellen E; Meers Z; Pil L; Goossens MC
Eur J Cancer Prev; 2024 Mar; 33(2):181-184. PubMed ID: 38190189
[TBL] [Abstract][Full Text] [Related]
25. Social inequalities in cervical cancer screening: a discrete choice experiment among French general practitioners and gynaecologists.
Raginel T; Grandazzi G; Launoy G; Trocmé M; Christophe V; Berchi C; Guittet L
BMC Health Serv Res; 2020 Jul; 20(1):693. PubMed ID: 32718319
[TBL] [Abstract][Full Text] [Related]
26. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
Jensen H; Svanholm H; Støvring H; Bro F
J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
[TBL] [Abstract][Full Text] [Related]
27. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
28. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
[TBL] [Abstract][Full Text] [Related]
29. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
30. A population-based combination strategy to improve the cervical cancer screening coverage rate in Bamako, Mali.
Téguété I; Tounkara FK; Diawara B; Traoré S; Koné D; Bagayogo A; Sissoko A; Traoré CB
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):794-801. PubMed ID: 33560520
[TBL] [Abstract][Full Text] [Related]
31. Cervical cancer screening coverage in a high-incidence region.
Navarro C; Fonseca AJ; Sibajev A; Souza CI; Araújo DS; Teles DA; Carvalho SG; Cavalcante KW; Rabelo WL
Rev Saude Publica; 2015; 49():17. PubMed ID: 25741655
[TBL] [Abstract][Full Text] [Related]
32. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
Veerus P; Arbyn M; Amati C; Paolo B;
Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the organization of the mass screening program for cervix cancer in northern Limburg].
Spee MH; van Gastel J
Ned Tijdschr Geneeskd; 1992 Nov; 136(47):2327-31. PubMed ID: 1461304
[TBL] [Abstract][Full Text] [Related]
34. Modeling cost-effectiveness of cervical cancer screening in Hungary.
Vokó Z; Nagyjánosi L; Margitai B; Kövi R; Tóth Z; László D; Kaló Z
Value Health; 2012 Jan; 15(1):39-45. PubMed ID: 22264970
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
Wang J; Elfström KM; Andrae B; Nordqvist Kleppe S; Ploner A; Lei J; Dillner J; Sundström K; Sparén P
Int J Cancer; 2020 Mar; 146(5):1230-1240. PubMed ID: 31107987
[TBL] [Abstract][Full Text] [Related]
36. [The state of organized cervical screening program in Hungary in 2006].
Kovacs A; Dobrossy L; Budai A; Boncz I; Cornides A
Orv Hetil; 2007 Mar; 148(12):535-40. PubMed ID: 17444018
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary.
Vokó Z; Nagyjánosi L; Kaló Z
BMC Public Health; 2012 Oct; 12():924. PubMed ID: 23110361
[TBL] [Abstract][Full Text] [Related]
38. Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses.
Sultana F; Roeske L; Malloy MJ; McDermott TL; Saville M; Brotherton JML
PLoS One; 2020; 15(1):e0228042. PubMed ID: 31995585
[TBL] [Abstract][Full Text] [Related]
39. Non-participation in cervical cancer screening according to health, lifestyle and sexual behavior: A population-based study of nearly 15,000 Danish women aged 23-45 years.
Harder E; Hertzum-Larsen R; Frederiksen K; Kjær SK; Thomsen LT
Prev Med; 2020 Aug; 137():106119. PubMed ID: 32387298
[TBL] [Abstract][Full Text] [Related]
40. [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].
Mignotte H; Perol D; Fontanière B; Nachury LP; Blanc-Jouvand A; Fouillat V; Chauvin F; Lasset C
Bull Cancer; 1999 Jun; 86(6):573-9. PubMed ID: 10417430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
